2018International Journal of Pharmaceutical Quality AssuranceOpen access

Presence of Extended-Spectrum β-Lactamases Genes in E. coli Isolated from Farm Workers in the South of London

Mohammed Fadhil AboKsour

Open full text 2 citations

Abstract

Sixty - four isolates of E. coli were isolated from urine, stool, and skin samples of farm workers in south of London. Antibiotic susceptibilities were tested by using the agar dilution protocol by using amikacin, ampicillin, aztreonam, meropenem, cefotaxime, ceftazidime, ceftriaxone, ciprofloxacin, gentamycin, imipenem, ofloxacin, and cefpodoxime. Determination of ESBL of E. coli isolates was performed according to CLSI by using two discs method. PCR was used to detect of CTX-M, TEM, and SHV genes and genotyped E. coli isolates which were reported as ESBL producers in both two disks and E-test methods. The results illustrated that thirty-eight isolates (n=64, 59 %) had multi drug resistance, and the resistance results recorded as the follows; imipenem (0%), meropenem (0%), ofloxacin (7%), ciprofloxacin (10%), ampicillin (89%), cefpodoxime (86%), aztreonam (82%), gentamycin (70%), ceftriaxone (31%), ceftazidime (37%), cefotaxime (62%), and amikacin (65%). Twelve of E. coli isolates (n=64, 18.7%) were phenotypically ESBL producers. eleven isolated of ESBL phenotype-positive E. coli carried bla genes (n=12, 91.7 %), blaCTX-M was found in eleven isolates (91.6 %), blaTEM in eight isolates (66.6 %), and blaSHV in one isolate (8.3 %).

About this research paper

What this paper is about

Sixty - four isolates of E. coli were isolated from urine, stool, and skin samples of farm workers in south of London. Antibiotic susceptibilities were tested by using the agar dilution protocol by using amikacin, ampicillin, aztreonam, meropenem, cefotaxime, ceftazidime, ceftriaxone, ciprofloxacin, gentamycin, imipenem, ofloxacin, and cefpodoxime. Determination of ESBL of E. coli isolates was performed according to CLSI by using two discs method. PCR was used to detect of CTX-M, TEM, and SHV genes and genotyped E. coli isolates which were reported as ESBL producers in both two disks and E-test methods. The results illustrated that thirty-eight isolates (n=64, 59 %) had multi drug resistance, and the resistance results recorded as the follows; imipenem (0%), meropenem (0%), ofloxacin (7%), ciprofloxacin (10%), ampicillin (89%), cefpodoxime (86%), aztreonam (82%), gentamycin (70%), ceftriaxone (31%), ceftazidime (37%), cefotaxime (62%), and amikacin (65%). Twelve of E. coli isolates (n=64, 18.7%) were phenotypically ESBL producers. eleven isolated of ESBL phenotype-positive E. coli carried bla genes (n=12, 91.7 %), blaCTX-M was found in eleven isolates (91.6 %), blaTEM in eight isolates (66.6 %), and blaSHV in one isolate (8.3 %).

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Sixty - four isolates of E. coli were isolated from urine, stool, and skin samples of farm workers in south of London. Antibiotic susceptibilities were tested by using the agar dilution protocol by using amikacin, ampicillin, aztreonam, meropenem, cefotaxime, ceftazidime, ceftriaxone, ciprofloxacin, gentamycin, imipenem, ofloxacin, and cefpodoxime. Determination of ESBL of E. coli isolates was performed according to CLSI by using two discs method. PCR was used to detect of CTX-M, TEM, and SHV genes and genotyped E. coli isolates which were reported as ESBL producers in both two disks and E-test methods. The results illustrated that thirty-eight isolates (n=64, 59 %) had multi drug resistance, and the resistance results recorded as the follows; imipenem (0%), meropenem (0%), ofloxacin (7%), ciprofloxacin (10%), ampicillin (89%), cefpodoxime (86%), aztreonam (82%), gentamycin (70%), ceftriaxone (31%), ceftazidime (37%), cefotaxime (62%), and amikacin (65%). Twelve of E. coli isolates (n=64, 18.7%) were phenotypically ESBL producers. eleven isolated of ESBL phenotype-positive E. coli carried bla genes (n=12, 91.7 %), blaCTX-M was found in eleven isolates (91.6 %), blaTEM in eight isolates (66.6 %), and blaSHV in one isolate (8.3 %).

Key concepts: Cefpodoxime, Aztreonam, Cefotaxime, Ceftazidime, Meropenem, Imipenem, Microbiology, Amikacin

Related papers

Back to paper searchBrowse research topicsOriginal source
Presence of Extended-Spectrum β-Lactamases Genes in E. coli Isolated from Farm Workers in the South of London — Research Paper | ScholarLens